# Source: Tether Strategic Stake in Blackrock Neurotech

**Type:** source
**Status:** Useful
**Confidence:** High
**Source Type:** Press Release
**URL:** https://tether.io/news/tether-takes-strategic-stake-in-leading-brain-computer-interface-company-blackrock-neurotech/
**Publisher:** Tether
**Accessed:** 2026-05-09
**Updated:** 2026-05-09

## Summary

April 2024 announcement of Tether's $200 million strategic investment in Blackrock Neurotech through Tether Evo, the company's emerging-technologies venture arm. The release describes the investment as making Tether the majority stakeholder in Blackrock and frames the use of funds around clinical commercialization and continued R&D.

## Useful Claims

- Tether announced a $200 million strategic investment in Blackrock Neurotech in April 2024.
- The investment was made through Tether Evo, Tether's venture arm for emerging technologies.
- The release states that the investment made Tether the majority stakeholder in Blackrock Neurotech.
- The release identifies Blackrock as a Salt Lake City–based BCI company founded in 2008 by Dr. Florian Solzbacher and Marcus Gerhardt.

## Reliability Notes

Useful for the existence, size, and majority-stake framing of the investment. The strategic and governance implications for an FDA-regulated medical-device company under crypto-treasury ownership are not addressed and should be triangulated against later corporate disclosures. As an investor press release, treat use-of-funds language as intent rather than verified outcome.

## Related Pages

- [Blackrock Neurotech](blackrock-neurotech.md)